Rakesh Dixit
President & Chief Executive Officer Bionavigen Oncology
Dr. Dixit currently serves as President and CEO of Bionavigen, a biopharmaceutical company specializing in consulting and drug hunting for biologic, cell and gene therapy and small molecule drug development. He is also President and CSO of Regio Biosciences, an AstraZeneca Spinoff company. Dr. Dixit is an accomplished executive, inventor, and scientist with over 30 years of success with top biotechnology and pharmaceutical companies, including Merck, Johnson & Johnson, Medimmune, and AstraZeneca. He was a key contributor to successful approval of biotherapeutics, including five biologics (including antibodies and immunotoxins) and four small molecule pharmaceuticals. He was honored in 2020 by the World ADC Forum with its most prestigious award of Long-Standing Contributor to ADCs.
Seminars
- Identifying which toxicities are reasonably predictable from animal or in vitro studies
- Discussing toxicities that are still difficult to understand and where things are “falling apart”
- Exploring what can be done to further enhance the understanding of ADC toxicities, including focusing on key toxicities such as ocular and lung regions
